Frontotemporal Dementia with Motor Neuron Disease (FTD-ALS): A Patient Guide
At a Glance
FTD-ALS is a spectrum in which changes in behavior, thinking, or language occur alongside motor neuron weakness. A coordinated care team should address breathing, swallowing, safety, communication, caregiver support, and early legal planning.
Disclaimer: This guide supplements—not replaces—individual neurologic, respiratory, swallowing, genetic, legal, and palliative-care advice. The bracketed codes indicate the medical literature citations supporting these statements.
Frontotemporal dementia with motor neuron disease (FTD-ALS) is a complex neurodegenerative condition where two different types of decline—cognitive and physical—unfold at the same time. While doctors once viewed these as separate diseases, they are now understood as part of a single biological spectrum [1].
Understanding the Spectrum Terminology:
Not every person gets full dementia and full ALS. The accepted ALS-frontotemporal spectrum includes subtle cognitive or behavioral impairment, ALS with behavioral or cognitive impairment, and full ALS-FTD. Motor, cognitive, behavioral, and language features can emerge in different orders and degrees.
In this spectrum, the brain’s frontal and temporal lobes, which govern personality and language, deteriorate alongside the motor neurons that control muscle movement. This progression means that a person may experience changes in behavior, empathy, and judgment while simultaneously facing muscle weakness and speech difficulties [2].
The biological bridge between these two conditions is often found in the behavior of a protein called TDP-43, which misfolds and clumps within nerve cells in most cases, or through a specific genetic repeat expansion known as C9orf72 [3]. These underlying mechanisms cause a cascade of damage that disrupts how cells function and communicate. For caregivers, understanding this link is vital because it explains why a loved one’s “personality changes” are just as much a physical symptom of the disease as their “muscle weakness.” The behavior is not a choice; it is a direct result of the brain’s changing structure [4].
Living with ALS-FTSD requires a specialized approach to care that prioritizes several critical areas. First, receiving care from a multidisciplinary team is essential, as it brings together neurologists, therapists, and social workers who can address both the physical and behavioral symptoms in one place [5]. Second, proactive support for breathing and swallowing is the cornerstone of managing the physical side of the disease [6]. Third, because the condition can affect a person’s reasoning and safety awareness, caregivers must focus on behavioral management and home safety to prevent accidents [7]. Finally, because the window for clear communication can be short, completing advanced directives and legal planning early—while the person still has the capacity to express their wishes—is a high priority [8].
While the dual nature of this diagnosis is undeniably challenging, being informed and supported allows you to stay ahead of the disease’s progression. By focusing on symptom management, safety, and early planning, you can help preserve your loved one’s comfort and dignity throughout their journey. This guide is designed to empower you with the knowledge needed to navigate these complexities alongside your medical team [9].
In this guide
7 chapters
The Biology of the FTD-ALS Spectrum
Learn how the FTD-ALS spectrum affects behavior, language, movement, and judgment. Understand TDP-43 biology, C9orf72 testing, screening, and caregiver support.
Symptoms and Progression in FTD-ALS
Learn how FTD-ALS symptoms change over time, including apathy, language problems, muscle weakness, swallowing changes, and urgent warning signs for families.
The Road to a Diagnosis: Tests and Mimics
Learn how doctors diagnose the FTD-ALS spectrum with neurological exams, ECAS, EMG, MRI, NfL, genetic testing, and tests that rule out look-alike conditions.
Standard of Care and Your Team
Learn how FTD-ALS care uses riluzole and edaravone, manages swallowing and breathing, and coordinates specialists while helping families plan for change.
Respiratory and Nutritional Support
Learn how caregivers can manage frontotemporal dementia with motor neuron disease, recognize breathing emergencies, and plan NIV, cough assist, and PEG care.
Day-to-Day Management and Caregiver Priorities
Learn practical FTD-ALS caregiving strategies for behavior, communication, sleep, safety, AAC, routines, respite, and urgent medical concerns.
Prognosis and Planning for the Future
Understand the FTD-ALS prognosis, how symptom onset can affect survival, and why advance directives, palliative care, hospice, and communication plans matter.
Common questions in this guide
What is FTD-ALS, and is it the same as ALS or frontotemporal dementia?
What symptoms can occur with FTD-ALS?
Why can someone with FTD-ALS seem to have a different personality?
What specialists should be involved in FTD-ALS care?
How can caregivers help with breathing, swallowing, and safety?
Why should advance directives and legal planning happen early?
How is decision-making capacity evaluated in FTD-ALS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the current symptoms, does my loved one fit the profile of ALS with behavioral impairment (ALS-bi) or the full FTD-ALS diagnosis?
- 2.How will our care team coordinate between the movement specialists and the cognitive/behavioral specialists?
- 3.What is the best way to monitor for new respiratory or swallowing changes while also managing behavioral apathy or resistance?
- 4.Can you provide a formal assessment of decision-making capacity to help us understand how much the patient can participate in planning?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.
Strong MJ, Abrahams S, Goldstein LH, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(3-4)):153-174 doi:10.1080/21678421.2016.1267768.
PMID: 28054827 - 2
Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement.
Rusina R, Vandenberghe R, Bruffaerts R
Diagnostics (Basel, Switzerland) 2021; (11(4)) doi:10.3390/diagnostics11040624.
PMID: 33808458 - 3
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.
Shi Y, Lin S, Staats KA, et al.
Nature medicine 2018; (24(3)):313-325 doi:10.1038/nm.4490.
PMID: 29400714 - 4
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
Saxon JA, Thompson JC, Harris JM, et al.
Journal of neurology, neurosurgery, and psychiatry 2020; (91(12)):1304-1311 doi:10.1136/jnnp-2020-323969.
PMID: 33055142 - 5
Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.
Vucic S, Shahrizaila N, Kano O, et al.
The Lancet regional health. Western Pacific 2025; (62()):101684 doi:10.1016/j.lanwpc.2025.101684.
PMID: 41018945 - 6
Cognitive and behavioural impairment in amyotrophic lateral sclerosis.
Pender N, Pinto-Grau M, Hardiman O
Current opinion in neurology 2020; (33(5)):649-654 doi:10.1097/WCO.0000000000000862.
PMID: 32833751 - 7
Sleep Disturbances in Frontotemporal Dementia.
McCarter SJ, St Louis EK, Boeve BF
Current neurology and neuroscience reports 2016; (16(9)):85 doi:10.1007/s11910-016-0680-3.
PMID: 27485946 - 8
Amyotrophic lateral sclerosis: a clinical review.
Masrori P, Van Damme P
European journal of neurology 2020; (27(10)):1918-1929 doi:10.1111/ene.14393.
PMID: 32526057 - 9
Palliative care principles in ALS.
Shoesmith C
Handbook of clinical neurology 2023; (191()):139-155 doi:10.1016/B978-0-12-824535-4.00007-0.
PMID: 36599506
This page is for informational purposes only and does not constitute medical advice. It cannot replace individualized neurologic, respiratory, swallowing, genetic, legal, or palliative-care guidance for someone with FTD-ALS; discuss specific decisions with the treating team.
Get notified when new evidence is published on Frontotemporal dementia with motor neuron disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.